Bracebridge Capital »

Atrium Therapeutics shares owned by Bracebridge Capital

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Bracebridge Capital from 13F filings

Historical chart of Bracebridge Capital investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by Bracebridge Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by Bracebridge Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.9M 139k 13.37

More positions owned by Bracebridge Capital

Ishares Tr Russell 2000 Etf Put Option (IWM)
Spdr Gold Tr Put Put Option
Spdr Gold Tr Gold Shs (GLD)
Select Sector Spdr Tr Put Put Option
State Str Spdr S&p 500 Etf T Call Call Option
Ishares Tr Put Put Option
Ishares Tr Call Call Option
Spdr Gold Tr Call Call Option
Uniti Group Com Shs (UNIT)
Tesla Put Put Option
Tesla Call Call Option
Salesforce Call Call Option
Warner Bros Discovery Call Call Option
Ares Capital Corp Put Put Option
Ishares Tr Expanded Tech Put Option (IGV)

View all positions for Bracebridge Capital

Top funds holding Atrium Therapeutics

BlackRock
Susquehanna International
RA Capital Management
Vanguard Capital Management
TIG Advisors
Pentwater Capital Management
Sessa Capital IM
Goldman Sachs Group
Farallon Capital Management
Vanguard Portfolio Management
Geode Capital Management
683 Capital Management
Bellevue Group
State Street Corporation
Weiss Asset Management LP[1

View all funds holding Atrium Therapeutics